InVivo Therapeutics Announces Strategic Corporate Restructuring – Business Wire (press release)

CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that it
is executing a strategic restructuring in order to focus on The INSPIRE
Study: InVivo Study of Probable Benefit of the Neuro-Spinal
Scaffold for Safety and Neurologic Recovery in Subjects with
Complete Thoracic AIS A Spinal Cord Injury. The strategic restructuring
will allow the company to concentrate its efforts on reopening patient
enrollment for INSPIRE, completing INSPIRE, and filing a Humanitarian
Device Exemption (HDE) submission for the Neuro-Spinal Scaffold.
The INSPIRE Study is designed to demonstrate the safety and probable
benefit of the Neuro-Spinal …